Dawaa Reference

Clinical reference

Night sweats

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class AS10.01 - condition scope only, no dose · NICE NG12: Suspected cancer: recognition and referral (recommendation 1.10) - https://www.ncbi.nlm.nih.gov/books/NBK555330/ · No dose - referral pathway, no medicine given in primary care

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (RECOGNITION & REFERRAL)

1st line
Adult dose and duration

A symptom requiring work-up for tuberculosis, lymphoma, HIV, or menopause rather than a condition treated directly; management depends entirely on the underlying cause. - Refer

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

A symptom requiring work-up for tuberculosis, lymphoma, HIV, or menopause rather than a condition treated directly; management depends entirely on the underlying cause.

Cautions
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - Persistence beyond a few weeks, accompanying weight loss or fever (TB, lymphoma), chronic cough or haemoptysis, palpable lymphadenopathy, or known or suspected HIV risk.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.